-
1
-
-
0037235229
-
Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: Emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study
-
Akuta N, Tsubota A, Suzuki F, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. 2003. Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: Emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study. J Hepatol 38:91-97.
-
(2003)
J Hepatol
, vol.38
, pp. 91-97
-
-
Akuta, N.1
Tsubota, A.2
Suzuki, F.3
Suzuki, Y.4
Hosaka, T.5
Someya, T.6
Kobayashi, M.7
Saitoh, S.8
Arase, Y.9
Ikeda, K.10
Kumada, H.11
-
2
-
-
0031780935
-
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
-
Allen MI, Deslauriers M, Andrews CW, Tippies GA, Walters KA, Tyrrell DL, Brown N, Condreay LD. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
-
(1998)
Hepatology
, vol.27
, pp. 1670-1677
-
-
Allen, M.I.1
Deslauriers, M.2
Andrews, C.W.3
Tippies, G.A.4
Walters, K.A.5
Tyrrell, D.L.6
Brown, N.7
Condreay, L.D.8
-
3
-
-
17744383748
-
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
-
Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavvalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. 2001. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy. Hepatology 33:963-971.
-
(2001)
Hepatology
, vol.33
, pp. 963-971
-
-
Boni, C.1
Penna, A.2
Ogg, G.S.3
Bertoletti, A.4
Pilli, M.5
Cavallo, C.6
Cavvalli, A.7
Urbani, S.8
Boehme, R.9
Panebianco, R.10
Fiaccadori, F.11
Ferrari, C.12
-
4
-
-
0037230411
-
Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: Comparison with HBV from a patient with acute hepatitis infected from the same infectious source
-
Chen Y, Michitaka K, Matsubara H, Yamamoto K, Horiike N, Onji M. 2003. Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: Comparison with HBV from a patient with acute hepatitis infected from the same infectious source. J Hepatol 38:84-90.
-
(2003)
J Hepatol
, vol.38
, pp. 84-90
-
-
Chen, Y.1
Michitaka, K.2
Matsubara, H.3
Yamamoto, K.4
Horiike, N.5
Onji, M.6
-
5
-
-
0028916425
-
Hepatitis B virus immunopathogenesis
-
Chisari FV. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
-
(1995)
Annu Rev Immunol
, vol.13
, pp. 29-60
-
-
Chisari, F.V.1
-
6
-
-
0028235641
-
Classification of chronic hepatitis: Diagnosis, grading, and staging
-
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. 1994. Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 19:1513-1520.
-
(1994)
Hepatology
, vol.19
, pp. 1513-1520
-
-
Desmet, V.J.1
Gerber, M.2
Hoofnagle, J.H.3
Manns, M.4
Scheuer, P.J.5
-
7
-
-
0033592764
-
Lamivudine as initial treatment for chronic hepatitis B in the United States
-
DienstagJL, Schiff ER, Wright TL, Perrillo RP, Kann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. 1999. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341:1256-1263.
-
(1999)
N Engl J Med
, vol.341
, pp. 1256-1263
-
-
Dienstag, J.L.1
Schiff, E.R.2
Wright, T.L.3
Perrillo, R.P.4
Kann, H.W.5
Goodman, Z.6
Crowther, L.7
Condreay, L.D.8
Woessner, M.9
Rubin, M.10
Brown, N.A.11
-
8
-
-
0036590392
-
Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
-
Horiike N, Akbar SMF, Ninomiya T, Abe M, Michitaka K, Onji M. 2002. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res 23:38-47.
-
(2002)
Hepatol Res
, vol.23
, pp. 38-47
-
-
Horiike, N.1
Akbar, S.M.F.2
Ninomiya, T.3
Abe, M.4
Michitaka, K.5
Onji, M.6
-
9
-
-
11844306534
-
In vivo immunization by vaccine therapy following virus suppression by lamivudine: A novel approach for treating patients with chronic hepatitis B
-
Horiike N, Akbar SMF, Michitaka K, Joukou K, Yamamoto K, Kojima N, Hiasa Y, Abe M, Onji M. 2005. In vivo immunization by vaccine therapy following virus suppression by lamivudine: A novel approach for treating patients with chronic hepatitis B. J Clin Virol 32:156-161.
-
(2005)
J Clin Virol
, vol.32
, pp. 156-161
-
-
Horiike, N.1
Akbar, S.M.F.2
Michitaka, K.3
Joukou, K.4
Yamamoto, K.5
Kojima, N.6
Hiasa, Y.7
Abe, M.8
Onji, M.9
-
10
-
-
0036461318
-
Immunology of hepatitis B infection
-
Jung M-C, Pape GR. 2002. Immunology of hepatitis B infection. Lancet Infect Dis 2:43-50.
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 43-50
-
-
Jung, M.-C.1
Pape, G.R.2
-
11
-
-
0346786525
-
Continued lamivudine therapy in patients with chronic hepatitis B
-
Kumada H. 2003. Continued lamivudine therapy in patients with chronic hepatitis B. Intervirology 46:377-387.
-
(2003)
Intervirology
, vol.46
, pp. 377-387
-
-
Kumada, H.1
-
12
-
-
0032499913
-
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
-
Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. 1998. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339: 61-68.
-
(1998)
N Engl J Med
, vol.339
, pp. 61-68
-
-
Lai, C.L.1
Chien, R.N.2
Leung, N.W.3
Chang, T.T.4
Guan, R.5
Tai, D.I.6
Ng, K.Y.7
Wu, P.C.8
Dent, J.C.9
Barber, J.10
Stephenson, S.L.11
Gray, D.F.12
-
13
-
-
0033802362
-
Long-term therapy of chronic hepatitis B with lamivudine
-
Lau DTY, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schnidt P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle J. 2000. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828-834.
-
(2000)
Hepatology
, vol.32
, pp. 828-834
-
-
Lau, D.T.Y.1
Khokhar, M.F.2
Doo, E.3
Ghany, M.G.4
Herion, D.5
Park, Y.6
Kleiner, D.E.7
Schnidt, P.8
Condreay, L.D.9
Gauthier, J.10
Kuhns, M.C.11
Liang, T.J.12
Hoofnagle, J.13
-
14
-
-
0032783679
-
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
-
Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. 1999. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 30:567-572.
-
(1999)
Hepatology
, vol.30
, pp. 567-572
-
-
Liaw, Y.F.1
Chien, R.N.2
Yeh, C.T.3
Tsai, S.L.4
Chu, C.M.5
-
15
-
-
10844242136
-
High frequency of functional anti-YMDD and mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B
-
Lin CL, Tsal SL, Lee TH, Chien RN, Liao SK, Liaw YF. 2005. High frequency of functional anti-YMDD and mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B. Gut: 54:152-161.
-
(2005)
Gut
, vol.54
, pp. 152-161
-
-
Lin, C.L.1
Tsal, S.L.2
Lee, T.H.3
Chien, R.N.4
Liao, S.K.5
Liaw, Y.F.6
-
16
-
-
84984548357
-
Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences
-
Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. 2001. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences. Hepatology 34:583-589.
-
(2001)
Hepatology
, vol.34
, pp. 583-589
-
-
Liu, C.J.1
Chen, P.J.2
Lai, M.Y.3
Kao, J.H.4
Chen, D.S.5
-
17
-
-
84984585828
-
A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation
-
Liu C-J, Chen P-J, Lai M-Y, Kao JH, Chang CF, Wu HL, Shau WY, Chen DS. 2003. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 124:80-90.
-
(2003)
Gastroenterology
, vol.124
, pp. 80-90
-
-
Liu, C.-J.1
Chen P-J, L.M.-Y.2
Kao, J.H.3
Chang, C.F.4
Wu, H.L.5
Shau, W.Y.6
Chen, D.S.7
-
18
-
-
0027142488
-
Long-term follow-up of chronic hepatitis B patients treated with Interferon alpha
-
Lok AS, Chung HT, Liu VW, Ma OC. 1993. Long-term follow-up of chronic hepatitis B patients treated with Interferon alpha. Gastroenterology 105:1833-1835.
-
(1993)
Gastroenterology
, vol.105
, pp. 1833-1835
-
-
Lok, A.S.1
Chung, H.T.2
Liu, V.W.3
Ma, O.C.4
-
19
-
-
0000532607
-
Epidemiology of viral hepatitis
-
Mast EE, Alter MJ. 1993. Epidemiology of viral hepatitis. Sem Virol 4:273-283.
-
(1993)
Sem Virol
, vol.4
, pp. 273-283
-
-
Mast, E.E.1
Alter, M.J.2
-
20
-
-
0032880610
-
Novel pattern of amino acid mutation in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B
-
Ogata N, Fujii K, Takigawa S, Nomoto M, Ichida T, Asakura H. 1999. Novel pattern of amino acid mutation in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B. J Med Virol 59:270-276.
-
(1999)
J Med Virol
, vol.59
, pp. 270-276
-
-
Ogata, N.1
Fujii, K.2
Takigawa, S.3
Nomoto, M.4
Ichida, T.5
Asakura, H.6
-
21
-
-
0001852147
-
Influence of B domain mutation (L528M) of the hepatitis B virus polymerase on replication ability and resistance to nucleoside analogues
-
Ono-Nita SK, Kato N, Shiratori Y, Yoshida H, Kato J, Goto T. 2000. Influence of B domain mutation (L528M) of the hepatitis B virus polymerase on replication ability and resistance to nucleoside analogues. Hepatology 32:393A.
-
(2000)
Hepatology
, vol.32
-
-
Ono-Nita, S.K.1
Kato, N.2
Shiratori, Y.3
Yoshida, H.4
Kato, J.5
Goto, T.6
-
22
-
-
0034235905
-
Adefovir Dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
-
Perrillo R, Schiff E, Yoshida E, Statlrt A, Hirsch K, Wright T, Gutfreund K, Lamy P, Murray A. 2000. Adefovir Dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32:129-134.
-
(2000)
Hepatology
, vol.32
, pp. 129-134
-
-
Perrillo, R.1
Schiff, E.2
Yoshida, E.3
Statlrt, A.4
Hirsch, K.5
Wright, T.6
Gutfreund, K.7
Lamy, P.8
Murray, A.9
-
23
-
-
0031033174
-
Clinical implications of lamivudine resistance by HBV
-
Schalm SW. 1997. Clinical implications of lamivudine resistance by HBV. Lancet 9044:3-4.
-
(1997)
Lancet
, vol.9044
, pp. 3-4
-
-
Schalm, S.W.1
-
24
-
-
3543081472
-
Basal core promoter and precore mutations in the Hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants
-
Tacke F, Gejrke C, Kuedde T, Heim A, Manns MP, Trautwein C. 2004. Basal core promoter and precore mutations in the Hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol 78:8524-8535.
-
(2004)
J Virol
, vol.78
, pp. 8524-8535
-
-
Tacke, F.1
Gejrke, C.2
Kuedde, T.3
Heim, A.4
Manns, M.P.5
Trautwein, C.6
-
25
-
-
0033000134
-
Serological detection of hepatitis B genotype by ELISA with monoclonal antibodies to type specific epitopes in the preS2-region products
-
Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, Mayumi M. 1999. Serological detection of hepatitis B genotype by ELISA with monoclonal antibodies to type specific epitopes in the preS2-region products. J Viral Methods 80:97-112.
-
(1999)
J Viral Methods
, vol.80
, pp. 97-112
-
-
Usuda, S.1
Okamoto, H.2
Iwanari, H.3
Baba, K.4
Tsuda, F.5
Miyakawa, Y.6
Mayumi, M.7
-
26
-
-
0034802516
-
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
-
Yuen MF, Sablon E, Hui CK, Yuan HJ, Decraemer H, Lai CL. 2001. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 34: 758-791.
-
(2001)
Hepatology
, vol.34
, pp. 758-791
-
-
Yuen, M.F.1
Sablon, E.2
Hui, C.K.3
Yuan, H.J.4
Decraemer, H.5
Lai, C.L.6
-
27
-
-
10744226572
-
Clinical outcome and virologic profile of severe hepatitis B exacerbation due to YMDD mutations
-
Yuen MF, Kato T, Mizokami M, Chan AO, Yuen JC, Yuan HJ, Wong DK, Sum SM, Ng IO, Fan ST, Lai CL. 2003. Clinical outcome and virologic profile of severe hepatitis B exacerbation due to YMDD mutations. J Hepatol 39:850-855.
-
(2003)
J Hepatol
, vol.39
, pp. 850-855
-
-
Yuen, M.F.1
Kato, T.2
Mizokami, M.3
Chan, A.O.4
Yuen, J.C.5
Yuan, H.J.6
Wong, D.K.7
Sum, S.M.8
Ng, I.O.9
Fan, S.T.10
Lai, C.L.11
|